1. Bisphosphonates and risk of oesophageal cancer: A meta‐analysis. Issue 3 (31st May 2020) Authors: Li, Minghao; Zhong, Muyan Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID ‐19 and the gastroenterologist. Issue 3 (31st May 2020) Authors: Tsai, Her Hsin Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Creating a sustainable quality improvement in hepatocellular carcinoma screening rates in a free access medical system; improved outcomes and lessons learned. Issue 3 (15th May 2020) Authors: Brazeau, Michael; Owen, Samuel; Taylor, Douglas; Rosa, Cesar; Morales‐Cardona, Amilcar Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Issue Information. Issue 3 (31st May 2020) Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Midodrine or albumin in paracentesis‐induced circulatory dysfunction: Author's reply. Issue 3 (31st May 2020) Authors: Kulkarni, Anand V.; Padaki Rao, Nagaraja Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Obeticholic acid for treatment of NAFLD—A drug in search of a disease. Issue 3 (25th May 2020) Authors: Malnick, Stephen; Mildiner, Sorcha; Neuman, Manuela G. Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prevention of paracentesis‐induced circulatory dysfunction‐ a systematic review and network meta‐analysis. Issue 3 (31st May 2020) Authors: Kumar, Karan; Mishra, Manjul Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prevention of paracentesis‐induced circulatory dysfunction—A systematic review and network meta‐analysis. Issue 3 (8th May 2020) Authors: Kulkarni, Anand V.; Kumar, Pramod; Singh, Siddharth; Sharma, Mithun; Talukdar, Rupjyoti; Murthy, Vivekananda H.V.; Singh, Virendra; Reddy, Nageshwar D; Rao, Nagaraja Padaki Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reporting trends of adverse effects from proton pump inhibitors to the food and drug administration. Issue 3 (5th May 2020) Authors: Kruchko, David H.; Patel, Ami P.; Villines, Dana; Surjancev, Aleksandar; Ehrenpreis, Eli D. Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Systematic review with meta‐analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy. Issue 3 (25th May 2020) Authors: Slaets, Leen; De Ridder, Filip; Lenz, Oliver; Beumont, Maria; Meyvisch, Paul; Verbinnen, Thierry Journal: GastroHep Issue: Volume 2:Issue 3(2020) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗